RxDoctor Payments Data
★ My doctorsLook up a doctor →

Amberlea Bradford Elliott

Neuroscience · Oklahoma City, OKNPI 1801382775

Payments from drug & device makers

$1,822in general payments, 2019–2025

Across 94 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$344
  • Merz Pharmaceuticals, LLC$214
  • AstraZeneca$165
  • Teva Pharmaceuticals USA, Inc.$140
  • UCB, Inc.$137
  • SK Life Science, Inc.$135
  • plus $687 from 18 others

What the payments were for

  • Food & beverage$1,822100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie20$344
Merz Pharmaceuticals, LLC9$214
AstraZeneca9$165
Teva Pharmaceuticals USA, Inc.6$140
UCB, Inc.6$137
SK Life Science, Inc.6$135
Bristol Myers Squibb6$105
CSL Behring3$65
Argenx US, Inc.3$61
Genentech USA, Inc.4$58
Catalyst Pharmaceuticals, Inc.3$56
Medtronic2$49
Impel Pharmaceuticals Inc.3$47
Corium, LLC3$39
Neurocrine Biosciences, Inc.2$29
Pfizer1$26
Acorda Therapeutics, Inc1$23
Johnson & Johnson1$23
Lilly USA, LLC1$21
Avion Pharmaceuticals1$20
Azurity Pharmaceuticals, Inc.1$17
Eisai Inc.1$16
Lundbeck LLC1$15
E.r. Squibb & Sons, L.L.C.1$15

How this compares

Too few neuroscience providers in Oklahomato place this figure against a meaningful peer group, so we don't.

Other neuroscience in Oklahoma City

Where these figures come from

Is this you, or does something look wrong? →